7:00 am
|
Registration/Continental Breakfast/Exhibits
|
8:00 am
|
Welcome and Announcements
Lars G. Svensson, MD, PhD
|
Session I: Prevention and Management of CV Risk Part 1
Moderator: Amy Zack, MD
|
8:15 am
|
Tools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a),apoB, Non HDL-C
Dennis Bruemmer, MD, PhD |
8:30 am
|
Statin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence
Vikas Sunder, MD
|
8:45 am
|
When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk
Ashish Sarraju, MD
|
9:00 am
|
Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both?
Dennis Bruemmer, MD, PhD |
9:15 am
|
Weight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications
Steve Nissen, MD
|
9:30 am
|
Keto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best “Diet: What is the Evidence and How to Apply in Clinical Practice
Julia Zumpano, RD, LD
|
9:45 am
|
Old and Evolving Strategies for Treatment-Resistant Hypertension
Luke Laffin, MD
|
10:00 am
|
Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions
Lee Kirksey, MD
|
10:15 am
|
Panel Discussion/Q&A
Session Faculty
|
10:35 am
|
Refreshment Break/Exhibits
|
Session II: Prevention and Management of Risk Part 2
Moderator: Luke Laffin, MD
|
10:55 am
|
Hormone Therapy and Heart Health: Debunking Myths, Embracing Evidence
Luke Laffin, MD |
11:05 am
|
The Intersection of Cardiovascular Disease and Chronic Kidney Disease: Strategies for Reducing Cardiovascular Risk
Crystal Gadegbeku, MD
|
11:20 am
|
Who Should Get a CAC? How Often? How to Use the Results to Assess Risk?
Milind Desai, MD
|
11:35 am
|
Management of CV Issues in the Elderly: Geriatric Cardiology
Ardeshir Hashmi, MD
|
11:50 am
|
Population Health Management: Interventions to Control Cardiovascular Disease Risk Factors: Current Status
LeRoi Hicks, MD
|
12:05 pm
|
Panel Discussion/Q&A
Session Faculty
|
12:25 pm
|
Lunch
|
Session III: Special Populations
Moderator: Deirdre Mattina, MD
|
1:25 pm
|
Cardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This?
Vikas Sunder, MD |
1:40 pm
|
Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health
Deirdre Mattina, MD
|
1:55 pm
|
Competitive Sports Participation in Athletes with Heart Disease: Evaluation and Management
Tamanna Singh, MD
|
2:05 pm
|
Cardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success
Patrick Collier, MD, PhD
|
2:20 pm
|
Panel Discussion/Q&A
Session Faculty
|
2:35 pm
|
Refreshment Break/Exhibits
|
Session IV: Essentials of CVD
Moderator: Venu Menon, MD
|
2:55 pm
|
Role of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography
Saberio Lo Presti Vega, MD
|
3:10 pm
|
Creating a Pathway for the Management of Stable Angina in Your Clinic: Structured Risk Assessment and Clinical Decision Making
Ben Alencherry, MD
|
3:25 pm
|
ANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management
Khalid Ziada, MD
|
3:40 pm
|
How Do I Manage my Post MI Patient (Including DAPT Guidelines/Duration/CardiacRehab)
Venu Menon, MD
|
3:55 pm
|
Cardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance?
Erik Van Iterson, PhD, MS
|
4:10 pm
|
Peripheral Artery Disease: Assessment and Clinical Decision Making
Lee Kirksey, MD
|
4:25 pm
|
Panel Discussion/Q&A
Session Faculty
|
4:40 pm
|
Adjourn
|